Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Orbimed Asia III Mauritius Ltd Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Orbimed Asia III Mauritius FVCI Ltd Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Orbimed ASIA III Mauritius FVCI Ltd Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Investor Meeting with the Company : Duro Capital, Singapore, Multi-Act Equity, Magma Ventures Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandrakumar Laxminarayan Rathi Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandrakumar Laxminarayan Rathi Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Motilal Oswal Financial Services Ltd Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandrakumar Laxminarayan Rathi Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd